The study of fibulin-1 as a novel biomarker in bronchial asthma and its association with disease severity
Dalal El Giziry, Nermine HossamEldin Zakaria, Abeer Hassan Kassem and 1 more
Egyptian Journal of Chest Disease and Tuberculosis · 2017
doi:10.1016/j.ejcdt.2016.12.003 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
A key feature of asthmatic airways is remodeling which involves thickening of the airway wall, altered deposition of extracellular matrix (ECM) proteins and increased airway smooth muscle (ASM) mass. Fibulin-1 (FBLN-1) assists in stabilizing the ECM which maintains airway function and structure by providing mechanical support in addition to constituting a dynamic and complex network that influences cellular function. The present study aimed at investigation of possible association between the fibulin-1 levels in asthmatic patients and its relation to asthma severity. Subjects: The study was carried out on forty five asthmatic patients and thirty control normal subjects age and sex matched. Methods: All subjects included in the present study were subjected to: full history taking, complete clinical examination, laboratory investigation and chest X-ray. Pulmonary function test and reversibility test. Serum samples from all studied patients and controls were taken for estimation of level of fibulin-1 Enzyme-linked immune-sorbent assay (ELISA). All asthmatic patients will be examined with fibroptic bronchoscope and bronchoalveolar lavage were taken for estimation of level of fibulin-1. Results: The mean level of serum fibulin-1 in asthmatic patients was 244.10 ± 98.28 pg/ml in mild group, 217.97 ± 121.16 pg/ml in moderate group, 172.20 ± 53.85 pg/ml in severe group compared to a mean level of 187.23 ± 67.97 pg/ml in control group. It was found that fibulin-1 increased in serum of asthmatic patients than in controls with statistical significant difference (p < 0.05) but there was no significant relation to asthma severity. Estimation of BAL fibulin-1 in the three asthmatic groups, the mean level of BAL fibulin-1 was 507.0 ± 152.27 pg/ml in mild group, 692.81 ± 207.14 pg/ml in moderate group, 702.0–127.67 pg/ml in severe group. It was found that fibulin-1 was increased in BAL of severe degree bronchial asthma than in mild and moderate degrees with statistical significant difference (p < 0.05). Conclusion: This may highlights the potential role of fibulin-1 in airway wall remodeling.
Abstract licence: CC BY-NC-SA
Cited by papers we hold2
- Corrected
Fibroblast-to-myofibroblast transition in bronchial asthma · 2018
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.